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The introduction of accurate methods to screen for genetic defects in
the adult, the newborn, and the fetus promises to increase man's
control over his own destiny. If that promise is to be realized,
however, careful planning will be needed to prevent the technology of
screening from imposing its own ethic on man. The invention of the
club enabled man to increase his ability to hunt for food,
and simultaneously to brutalize his fellow man. In the same way,
while advances in genetic screening could lead to an increase in self-
autonomy for a few, they may also encourage the sterilization of
those determined to be genetically "unfit" to reproduce and the
abortion of those judged "unfit" to be born.
While one hopes that the new techniques will be responsibly used
to prevent the genetic defects which now appear in over 200,000
infants annually in the United States, individual human rights of
privacy, confidentiality, self-determination and procreation can
probably be protected only by the legal process. The law is not likely
to be effective, however, unless the lawyers who advise clients, the
judges deciding cases, and the legislatures that pass laws understand
the basic technology of genetic screening and its potential
implications. Since the legal issues cannot be fully appreciated
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without some knowledge of the technology of screening, our
discussion begins with a brief outline of this subject.
The Technology of Genetic Screening
The physical basis of human heredity is the genes that are passed on
from parents to children. 1 Each gene encodes information specifying
a single gene product. Each gene product, either directly or in
combination with other gene products, determines a specific
inherited trait such as blood group, eye color or Rh factor. Human
genes are physically arranged in linear sequences along the
chromosomes found in the nucleus of each human cell. The germ
cells, ova in the female and sperm in the male, each contain a single
set of chromosomes consisting of 22 autosomall chromosomes, plus
one X chromosome in ova and 22 autosomal chromosomes, plus
one X or one Y chromosome in sperm.
Following fertilization of an ovum by a sperm, a human embryo is
formed whose genetic complement consists of all 44 autosomal
1. Seegenerallyanytextbookonhumangenetics, e.g., M. LEvrrAN& A. MONTAGU, TEXT-
BOOK ON HUmAN GENETICS (1971). Both DNA (deoxyribonucleic acid),and RNA (ribonucleic
acid) are linear sequences ofnucleotides. A gene is defined operationally as a specific sequence
of nucleotides (in DNA or RNA) which encodes the genetic information that specifies a single
gene product. Acting as a template, the specific nucleotide sequence of the DNA is transcribed
into an equivalent nucleotide sequence in RNA. There are four different nucleotides in RNA
(adenine, guanine, cytosine, and uracil) and each sequence of three nucleotides is a code word
specifying one of twenty different amino acids or, alternatively, encodes a punctuation mark in
the genetic message such as "end here." The number of possible genetic code words is just the
number of permutations of the four different nucleotides taken three at a time, i. e., 43 =64.
The genetic code is thus redundant, since the number of code words greatly exceeds the num-
ber necessary to code for all the amino acids plus punctuations. For instance, both guanine-
adenine-Ruanine and Ruanine-adenine-adenine are code words for the amino acid glutamic
acid. Translation of the genetic information in RNA consists in lining up in sequence the
amino acids specified by each nucleotide triplet in the RNA (i. e., the RNA stand serves as a
template) and joining the amino acids together to form a polypeptide chain. One or more
polypetide chains may later join together to become a protein molecule. For example, the
protein globin in hemoglobin forms when two alpha and two beta polypeptide chains fold
around each other to create a unique three-dimensional structure. The genetic disease sickle
cell anemia results from a defect in the DNA gene that codes for the beta polypeptide chain.
The defect consists in substitution of a single nucleotide (thymine for adenine) in the DNA
gene, which upon translation of the genetic information into the beta polypeptide of globin
results in the amino acid valine being substituted for glutamic acid in the amino acid residue
number six position in the beta polypeptide chain. Although each beta chain consists of 116
amino acids and each alpha chain is a sequence of 121 amino acids, this single amino acid sub-
stitution has serious consequences for an individual unable to produce normal globin: his red
blood cells assume a sickle shape and their ability to carry oxygen to his body tissues is sub-
stantially imparied. For further details concerning the molecular basis of heredity, see any
modern text on biochemistry, e.g., H.R. MAHLER & E.H. GORDES, BIOLOGICAL CHEMISTRY
(1966)
2. The sex chromosomes in a normal individual are two in number, denoted XX in the
female and XY in the male. All of the other 44 chromosomes are termed "autosomal chromo-
somes." An autosome is simply any chromosome other than a sex chromosome.
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chromosomes (22 from the mother and 22 from the father) plus the X
chromosome donated from the mother's ovum, plus either an X or Y
chromosome from the father's sperm, whichever happened to have
been present in the sperm. If the embryo receives an X chromosome
from the father's sperm, the embryo will have two X chromosomes
(XX), and will be female; if the sperm is carrying a Y chromosome
the embryo will be male (XY). Since the X and Y chromosomes
specify sex, they are termed the sex chromosomes.
With the exception of the germ cells, all other human cells (the
somatic cells) contain 46 chromosomes consisting of 22 pairs of
homologous chromosomes plus the two sex chromosomes. As the
embryo develops, its cell population multiplies by cell division. At
each cell division an identical complement of chromosomes is
distributed to each daughter cell. Each chromosome contains
upwards from one thousand genes, so that the full complement of
human genes is on the order of tens of thousands. Not all genes are
actively forming their gene products in all cells all of the time.
Instead, various genes are selectively activated and repressed in
different cells to create different cell types according to a carefully
controlled program of embryological development. A wide variety of
cell types, produced and maintained by selective gene repression
and activation, forms the patterned arrays of cells that make up the
tissues and organs of the human body.
A gene mutation is a physical change in a gene that causes the gene
to specify an altered gene product or to fail to function at all.
Mutations may result from an error in copying the gene preparatory
to cell division, from radiation (ultraviolet light, X or gamma
radiation), or from chemical mutagens. Most mutations are harmful
and many are lethal. A mutation may involve deletion or substitution
of genetic material at a single point (point mutation) or of a whole
segment of a gene. On a grosser level, breaks and rearrangements of
one or more chromosomes may occur leading to chromosomal
abnormalities.
Dominant and Recessive Inheritance
The inheritance of a mutant gene may or may not lead to genetic
disease depending upon the nature of the gene product the mutant
gene specifies and whether the individual inherited one normal copy
of the gene and one mutant copy, termed heterozygous, or inherited
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two mutant copies (one on each of the two homologous chromosomes
carrying the gene), termed homozygous. A mutant gene may be
located on an autosome or on either of the sex chromosomes X or Y.
Genes on the X chromosome are termed X-linked (sex-linked) and
those on the Y chromosome are termed Y-linked. If a mutant gene is
expressed in an individual who is heterozygous for that gene, the
mutant genetic trait (the phenotype)3 is a dominant trait. If the
mutant gene is expressed only in the homozygous state, the genetic
trait is termed recessive. Exceptions to the latter, however, are the
X-linked recessive disorders in which only a single recessive gene in
the male will give rise to a given trait or disease (e.g., hemophilia)."
Autosomal Dominant Inheritance
Autosomal dominant genetic diseases include, among others,
Huntington's chorea,l neurofibromatosis, 6 and Ehler-Danlos syn-
drome.7 An individual with an autosomal dominant genetic disease
is almost certainly heterozygous for the defective gene since a double
dose of the defective gene is usually lethal. One or both of his parents
must also have the disorder unless there has been a new mutation or
illegitimacy. An affected parent will transmit the disease to
approximately one half of his children without regard to the
children's sex. An unaffected child can never transmit the disease.
3. The genetic phenotype is the collection of observable properties (structural and func-
tional) produced by the interaction between the organism's genetic potential (its genotype) and
the environment in which it finds itself. Not all genes are expressed. Some gene products are
totally non-functional and produce no observable characteristics under any circumstances.
Other genes, however, may produce observable characteristics under favorable environmental
influences. Alternative forms of the same gene at a particular gene locus on a chromosome are
termed alleles. An individual's genotype might consist of a gene on a particular chromosome
and its allele b on the homologous chromosome. Ifgene B is expressed and gene b is not, then B
is the dominant allele and b is the recessive allele. For example, if B were the mutant gene that
gives rise to Huntington's chorea, and if b is the normal allele, then an individual with geno-
type Bb will express phenotypically Huntington's chorea.
4. Hemophilia is due to a hereditary deficiency of blood coagulation Factor VIII and is
characterized by spontaneous or traumatic hemorrhages, bleeding from the mouth, gums,
lips, and tongue, and appearance of blood in the urine. In hemophilia A, there is a deficiency
of antihemophilic factor A.
5. Huntington's chorea is a disorder of the central nervous system which usually develops in
adult life into progressive chorea (involuntary and irregular, often twisting and writhing,
movements of the extremities and the face), disturbed speech and dementia.
6. Neurofibromatosis is characterized by the presence of neurofibromas (i. e., tumors that
involve diffuse proliferation of peripheral nerve elements) in the skin or along the course of
peripheral nerves.
7. Ehler-Danlos syndrome is a connective tissue disorder whose clinical manifestations
include excessively soft joints that are subject to frequent dislocation, loose and fragile skin,
easy bruising and calcified cysts.
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Autosomal Recessive Inheritance
Autosomal recessive genetic diseases appear only in individuals who
are homozygous for the defective gene, i.e., a double dose of the
defective gene is required for the disease to be expressed. Either both
parents must be heterozygous (showing no obvious manifestation of
the disease) or one parent is heterozygous and one parent is
homozygous in whom the disease is also expressed. The first case will
obviously occur much more often than the second. Although the
heterozygous parents are usually clinically normal, some partial loss
of enzymatic function may be detected in persons heterozygous for
some metabolic disorders, and this fact is now being exploited in
prenatal genetic screening for heterozygous parents. Persons
heterozygous for recessive genetic disease are termed carriers and
major research efforts are underway to develop accurate and
efficient methods for detection of carriers. The list of hereditary
disorders for which methods of carrier detection are available is
continually growing and now includes, for example, hemophilia A, 8
muscular dystrophy (Duchenne),' phenylketonuria,10 sickle cell
anemia" and Tay-Sachs disease. 2
Each parent who is heterozygous for a recessive mutant gene faces
a 50 percent risk of transmitting that gene to his children. Thus, if a
man and his wife are each heterozygous they face a 25 percent risk
(1/2 x 1/)that their children will be affected (homozygous), and a 50
percent risk that their children will be carriers like themselves
(heterozygous). There is a 25 percent probability that any child of
theirs would be entirely free from the defective gene.
8. See note 4, supra.
9. Muscular dystrophy (Duchenne), also known as pseudohypertrophic infantile muscular
dystrophy, is the most common form of the muscular dystrophies. This sex-linked recessive
disorder begins in early childhood, affecting chiefly males, and is characterized by progressive
weakness and atrophy of the thigh, hip and back muscles, with resulting waddling gait and
forward curvature of the spine. Eventually the muscles of respiration, the heart and the
esophagus also atrophy.
10. Phenylketonuria (PKU) is a hereditary metabolic disorder in which there is a deficiency
of the enzyme phenylalanine hydroxylase, resulting in increased amounts of the amino acid
phenylalanine in the blood and excess phenylpyruvic acid and other acids in urine. Clinical
manifestations are mental retardation, eczema, and occasionally seizures.
11. See note 1, supra.
12. Tay-Sach's disease is a metabolic disorder which results in infantile idiocy, blindness,
and early death. For a complete list of genetic disorders for which methods are available for
detection of carriers, see A. MrLuNsKY, THE PRENATAL DIAGNOSIS OF HEREDrrARY
DISORDERs (1973).
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X-linked Inheritance
An X-linked genetic disease is either dominant or recessive, but in
either case if a male inherits from his mother an X chromosome
containing a defective gene, that gene will be expressed and he will be
affected by the disease. This is because, unlike the female who has
two X chromosomes, the male has only the one X chromosome, so
that a second copy of the gene is not available in the normal state to
produce a properly functioning gene product. The male's Y
chromosome contains quite a different set of genes (those necessary
for the development of the male sexual organs) from the X
chromosome, and the Y chromosome cannot make up for the
defective gene on the X chromosome. If the disease is recessive,
women who are carriers (heterozygous, X-linked) transmit the
mutant gene to half of their daughters, who will also be carriers,
and to half of their sons, who will be affected. Males affected with an
X-linked, recessive disease will transmit the mutant gene to all their
daughters, who will be carriers, and to none of their sons.
In the case of X-linked, dominant disorders, all the daughters of
an affected father will have the disorder, since the father transmits
his mutant X chromosome solely to his daughters, but none of his
sons will be affected unless the mother is also affected. The X-linked
diseases include, for example, glucose-6-phosphate dehydrogenase
deficiency, 3 various forms of muscular dystrophy, hemophilia, '
4
retinitis pigmentosa 5 and Lesch-Nyhan syndrome. 6
Polygenic Inheritance
Many genetic diseases and traits are controlled by multiple genes,
and environmental factors may also be important determinants of
the ultimate clinical picture. Among the diseases presently
13. Glucose-6-phosphate dehyrogenase deficiency is an inborn error of metabolism
affecting the conversion of glucose-6-phosphate to 6-phosphogluconic acid, resulting clinically
in hemolytic anemia.
14. See note 4, supra.
15. Retinitis pigmentosa involves the slow, progressive atrophy of the nerve elements of all
lawyers of the retina, clumping of pigment and attenuation of the retinal arterioles. Onset may
occur in childhood or later on, resulting in defective night vision, a constricted field of vision
and eventual blindness.
16. Lesch-Nyhan syndrome is a disease due to deficiency of the enzyme hypoxanthine-
guanine phosphoribosyltransferase. Clinical manifestations are mental retardation, spastic
cerebral palsy, choreathetosis (a condition characterized by both choreiform and athetoid
movements including involuntary, irregular, and often twisting and writhing movements of
the extremities and face) and self-mutilating biting. A list of X-linked genetic disorders
appears in R. GOODMAN, GENEnc DisORDERs OF MAN, 95 (1970).
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regarded by man as polygenic in origin are atherosclerosis, essential
hypertension and diabetes mellitus. Persons suffering from these
disorders are probably often unaware of any hereditary basis of their
disease and fail to obtain genetic counseling.
Chromosomal Abnormalities
Chromosomal abnormalities include cases of broken or rearranged
chromosomes, extra or missing chromosomes or parts of chromo-
somes. A chromosomal abnormality may occur uniformly through-
out the cells of an individual, or the individual may be a mosaic in
whom the chromosome number or structure or both differ in
different cells. The most common inherited chromosomal abnor-
mality in man is Down's syndrome17 (also termed mongolism) in
which three copies of chromosome 21 are present instead of the
normal two (hence the term trisomy 21). Among the more common
chromosome abnormalities are the sex chromosome disorders XXX
females, XYY males, Turner's syndrome18 (XO, i.e., the Y
chromosome is missing), and Klinefelter's syndrome19 (XXY). The
incidence of Down's syndrome and of the sex chromosome dis-
orders is heavily dependent upon the age of the mother. For
example, trisomy 21 occurs in about 1:2300 births for mothers
under the age of 20 years, 1:290 from 35 to 39 years, and 1:100
from 40 to 44 years, and increases to about 1:46 at 45 years of age
and over.2 0
Detection of Genetic Disease in the Fetus
Once it has been determined that a husband or wife or both carry a
defective gene and they have been counseled concerning the
possibilities of their future offspring also becoming carriers or
being affected with genetic disease, the couple must decide for
themselves whether to risk having children. Until recently, unless
17. Down's syndrome is a constellation of congenital defects including mental retardation
(whose severity varies among affected individuals) and atypical facial characteristics respon-
sible for the older descriptive term mongoloid idiocy.
18. Turner's sydrome is characterized by short stature, undifferentiated (streak) gonads
and variable abnormalities that may include webbing of the neck and cardiac defects. The
phenotype is female.
19. Klinefelter's syndrome is characterized by the presence of small, abnormal testes and
by an increase in urinary gonadotropins.
20. A. Milunsky, et al., Prenatal Genetic Diagnosis, 283 N. ENG. J. MED. 1370, 1371
(1970).
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the genetic disease was dominant, the parents would not ordinarily
know whether their child had the disease until after its birth.
However, recent developments in fetoscopy, 21 radiography,22 ultra-
sound, 3 and, most notably, in amniocentesis now allow detection
of a number of genetic diseases and of some serious anatomical
abnormalities in the fetus in utero prior to 20 weeks' gestation. This
means that even if carriers decide to have children in spite of the
risks, they may still choose to abort the fetus should antenatal
diagnosis reveal genetic defects.
The fetus is enveloped by a delicate membrane called the amnion
which is filled with amniotic fluid. Amniotic fluid is a complex
mixture similar to extracellular fluid and includes the fetal urinary
excretion of enzymes, amino acids and any abnormal metabolites.
Chemical analysis of the amniotic fluid can, therefore, reveal
certain genetic diseases in the fetus. 4 Of key significance is the fact
that amniotic fluid also contains cells offetal origin, derived mainly
from fetal skin and amnion2 s Once the fetal cells have been
obtained by amniocentesis, biochemical and cytogenetic16 studies
upon the cells directly or upon tissue cultures seeded with the fetal
cells may be performed to screen for biochemical defects and
chromosomal abnormalities. Amniocentesis consists of inserting a
needle through the mother's abdomen27 and drawing out a sample
21. Fetoscopy utilizes fiber optics to allow visualization of the fetus and may prove useful in
the antenatal diagnosis of congenital malformations. The risks of fetoscopy are such that it
should probably be reserved for high risk pregnant women who have already given birth to
children with serious congenital malformations such as spina bifida (incomplete closure of the
vertebral canal) and anencaphaly (absence of cerebrum and cerebellum and of the flat bones of
the skull). Emery, Antenatal Diagnosis: Limitations and Future Prospects, in MEDICAL
GErNEcs TODAY 294 (Birth Defects Original Article Series, no. 10, D. Bergsma ed. 1974).
22. The fetus may be studied directly by radiography to detect skeletal abnormalities, and
by amniography and fetography to detect soft tissue abnormalities. These methods are of
proven value only in later pregnancy. Emery, supra note 21, at 290.
23. Diagnostic ultrasound is useful in locating the fetus and placenta, and in detecting gross
structural abnormalities in the fetus. The procedure is apparently quite safe and often used in
conjunction with amniocentesis to locate the placenta and to determine the presence of twins.
Campbell, The Prediction of Fetal Maturity by Ultrasonic Measurement of the Biparietal
Diameter, 76 J. OBSTET. GYNAEC. Barr. Com. 603 (1969); Hellman, et al., Safety of
Diagnostic Ultrasound in Obstetrics, 1 LANCET 1133 (1970); Milunsky, et al., supra note 20.
24. Milunsky, et al., supra note 20 at 1370. Matalon and Dorfman, for example,-have
diagnosed Hurler's syndrome (lipochondrodystrophy) in utero by chemical analysis of
amniotic fluid. See generally Milunksy, et al., supra note 20, at 1444-45.
25. Id.
26. Cytogenetics is a hybrid science in which the methods of cytology are employed in the
study of chromosomes. The principal tool is the microscope which allows direct examination of
the chiomosomes and may reveal any gross structural abnormalities in the chromosomes, as
well as extra or missing chromosomes.
27. The needle may be inserted transvaginally but this appears to increase the risk of abor-
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of amniotic fluid. Amniocentesis cannot properly be performed
earlier than 14-16 weeks gestation for lack of sufficient amniotic
fluid, nor past the twentieth week.2 The risks of amniocentesis
include Rh sensitization, 9 hemorrhage, abortion, puncture and
induced abnormalities of the fetus, and abdominal pain and
peritonitis.30 Total risks to both the pregnant woman and the fetus
will probably amount to less than one percent.31
Where it is necessary to have a fairly large quantity of fetal cells
for biochemical or cytogenetic analysis, the cells are cultured for up
to eight weeks. Wherever possible, the use of uncultured cells will
avoid such a long delay. Uncultured fetal cells are used mainly for
sex prediction based on sex-chromatin and fluorescence studies.32
In satisfactory preparations the accuracy of sex prediction can
exceed 90 percent and serve, for example, as the basis for the
selective abortion of female fetuses of males affected with an
X-linked genetic disease.33
Detection of chromosomal abnormalities in fetal cells has
become an established and accurate procedure. Both fetal sex and
karyotype can be readily determined.34 Chromosome studies on
cultured amniotic fluid cells will ordinarily be undertaken where
one of the parents is a mosaic,3" or carries a translocation 6 which
causes a severe physical or mental abnormality. More commonly,
however, chromosome studies are undertaken because the mother
is 35 or older, since the fetus carried by such a mother faces
increased risk of trisomy 21 (Down's syndrome) and the sex
chromosome abnormalities."
tion and microbial contamination of the sample. Milunsky, et al., supra note 20; Turnbull, et
al., Antenatal Diagnosis of Fetal Abnormality with Special Reference to Amniocentesis, 66
PRoc. Roy. Soc. MED. 1115 (1973).
28. Turnbull, et al., supra note 27.
29. Queenan, et al., Role of Induced Abortion in Rhesus Immunization, 1 LANCET 815
(1971).
30. Creasman, Laurence & Thiede, Fetal Complications of Amniocentesis, 204 J.A.M.A.
949 (1949); Nadler, Prenatal Detection of Genetic Defects, 74 J. PED. 132 (1969).
31. Turnbull, et al., supra note 29, at 1115.
32. Emery, supra note 23, at 291.
33. Id.
34. Hsu, et al., Results and Pitfalls in Prenatal Cytogenetic Diagnosis, 10J. MED. GEN. 112
(1973); Milunsky, et al., supra note 20, at 1376.
35. A mosaic is an individual composed of cells of different genotypes. Mosaics are created
spontaneously by gene or chromosomal mutation in somatic cells.
36. A translocation is the transfer of a broken portion of a chromosome to adifferent part of
a homologous chromosome or to a nonhomologous chromosome. The result is that the
translocated chromosome portion is no longer where it belongs.
37. Emery, supra note 21, at 291. Methods to detect chromosomal abnormalities have
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Another important development in recent years has been the
development of methods to detect the presence of inherited
metabolic disorders in the fetus, using either uncultured or
cultured fetal cells. The list of metabolic disorders now diagnosable
in utero, while growing, is still quite limited.38 Important inherited
metabolic disorders not yet prenatally diagnosable include cystic
fibrosis39 (the most common hereditary metabolic disorder in
western society)40  and phenylketonuria. 41 Moreover, prenatal
diagnosis is not yet practical for the common hematological
disorders sickle cell anemia and glucose-6-phosphate dehydro-
genase deficiency. 4  A prenatal test for sickle cell anemia is
particularly desired since about one in 500 black infants in the
United States has this painful and debilitating disease of the red
blood cells.
43
Screening Newborns for Inherited
Metabolic Disorders
Among the states, Massachusetts seems to have the most extensive
program of screening newborns for inherited metabolic disorders.44
improved rapidly in recent years. New chromosome staining techniques now allow for the
specific recognition of individual chromosomes. Chromosomes stained with quinacrine
mustard, when viewed in the fluorescence miscroscope, reveal patterns of light and dark bands
along the lengths of the chromosomes that allow for the ready identification of various chromo-
some translocations. The Giemsa stain is complementary to the quinacrine fluorescence
method, revealing a different set of chromosomal details. Use of these methods depends upon
locating cells in metaphase under the microscope (i. e., cells in which the chromosomes are all
lined up at the metaphase plate preparatory to reassortment into the daughter cells during cell
division). Systems for automatic cytogenetic analysis that will take over the tedium of locating
metaphase cells and perform a karyotype analysis are under development. Such systems will be
required if chromosomal analyses on amniotic cells are to become routine for all pregnancies.
A. MILUNSKY, THE PRENATAL DIAGNOSIS OF HEREDITARY DISORDERS. 32 (1973).
38. For a list of hereditary biochemical disorders diagnosable in utero, see Emery, supra
note 21, at 292.
39. Brimblecombe, Screening for Cystic Fibrosis, 2 LANCET 1428 (1973).
40. Emery, supra note 21, at 292.
41. Milunsky, et al., supra note 22, at 1445.
42. Littlefield, et al., Prenatal Genetic Diagnosis: Status and Problems, in ETmICAL IssuEs
IN HUMAN GENETICS: GENETIC COUNSELING & THE USE OF GENETIC KNOWLEDGE, 43, 48
(Hilton & Callahan eds. 1973).
43. Id.
44. The Massachusetts statute appears to give the state Department of Health great flex-
ibility in determining which genetic screening programs will be undertaken. MAss. GEN.
LAWS ANN. ch. 76, § ISB (Supp. 1974). Participation in the sickle cell anemia screening
program is voluntary for most persons (§ 15B) but the commissioner of public health may
require that children susceptible to the disease submit to a blood test (§ 15A). New York State,
by contrasts, requires each infant to be tested within the first 28 days of life for PKU,
homozygous sickle cell disease, branched chain ketonuria, galactosemia, homocystinuria,
adenosine deminase deficiency, histidinemia, and such other diseases and conditions as the
commissioner of public health may designate. N.Y. PUB. HEALTH LAW 2500(a) McKinney
Supp. 1974).
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Umbilical cord blood is tested at birth for galactosemia4 ' and
maternal phenylketonuria. 46 A blood sample is taken from the baby
at 2-4 days of age in the hospital and tested for phenylketonuria,
maple-syrup-urine disease, ' 7 homocystinuria, 4 tyrosinosis4 9 and
galactosemia.5 0 Finally, a urine sample from the baby at 3-4 weeks
of age is tested for other metabolic and renal transport disorders."1
The routine screening of newborns is limited to metabolic disorders
and does not include screening for chromosomal abnormalities
since the costs would be prohibitive. The development of
automated cytogenetic analysis may some day make feasible
routine screening for chromosomal abnormalities in newborns.
Screening Children and Adults for
Inherited Disorders
A child or adult may undergo testing for genetic disease either
because he has been referred by his own physician to a genetic
counseling unit or because he is a relative of a person who is a
carrier or suffers from genetic disease. In addition, certain genetic
disorders are especially prevalent among some ethnic groups. For
instance, the hemoglobinopathies are most common among persons
of African descent and Tay-Sachs disease is most common among
Ashkenazic Jews. s" Accordingly, campaigns have been undertaken
to screen the North American Jewish population for Tay-Sachs
disease, and some states have required the testing of school children
for sickle cell anemia, although more recently some states have
45. Galactosemia is an inborn error of metabolism due to absence of the enzyme 1-phos-
phate uridyl transferase resulting in inability to convert galactose into glucose. Clinical
manifestations are a failure to thrive in infancy, jaundice, mental retardation, cataract
formation, and involvement of liver and spleen.
46. Levy, Newborn Screening forMetabolic Disorders, 288 N. ENG. J. MED. 1299 (1973).
47. Maple-syrup-urine disease is a deficiency of the enzyme branched chain keto acid de-
carboxylase, which results in abnormally high concentrations of the amino acids valine,
leucine, isoleucine, and the presence of the alloisoleucine in blood, urine, and cerebrospinal
fluid. Clinical manifestations include the maple-syrup-like odor of the urine noted shortly
after birth, and severe mental retardation, seizures and death if the severe infantile form of the
disease is not treated by diet.
48. Homocystinuria is due to absence or deficiency of the liver enzyme cystathionine syn-
thase. Clinikal manifestations are mental retardation, enlarged liver, cardiovascular and
skeletal disorders.
49. Tyrosinosis results from a deficiency of the enzyme p-hydroxylphenyl pyruvic oxidase in
early life. Clinical manifestations are similar to PKU and include failure to thrive, seizures,
gastrointestinal disturbances, and unless treated by diet, mental retardation.
50. Levy, supra note 46, at 1300.
51. Id.
52. R. Goodman, supra note 16, at 90.
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repealed or amended these laws. 3 The screening of children and
adults for genetic disease presents no special technical difficulties
except to maintain high accuracy and keep costs down so that the
methods used will be economically feasible for mass screening.
Legal Issues In Genetic Screening
There seems to be general agreement that the major goals of genetic
screening are "to find persons with particular genotypes in order to
fulfill such traditional medical objectives as the provision of care for
people who are sick and the prevention of disease."5s4 Screening
may be done to provide reproductive information, for research, or
to determine the incidence of various genetic disorders."5 Because
the legal issues depend on the circumstances under which genetic
screening is done, this discussion will be divided according to the
age of the screenee: prenatal, neonatal, and adult.
Prenatal Screening
As noted above, amniocentesis is usually performed around the
fifteenth week of pregnancy, with results available around the
twentieth week. Because no hospital routinely performs abortions
after the twentieth or twenty-first week of pregnancy, there is no
opportunity to rerun the test to confirm a diagnosis. Of course, as
in any other diagnostic test, mistakes can be made. Specifically,
one may obtain a false positive (a test that concludes that the fetus
is affected, when in fact it is not), or a false negative (a test that
concludes that the fetus is not affected, when in fact it is). The
abortion of one false positive, a normal male fetus falsely diagnosed
in a woman who had previously given birth to a Tay-Sachs
daughter, has already been reported in the literature5 6 Other
studies have revealed that a significant number of such errors is
predictable, and that negligence in obtaining an inadequate sample
of amniotic fluid, shipment difficulties, technical problems at the
53. Curran, The Questionable Virtues of Genetic Screening Laws, 64 Am. J. Pun. HEALTH
1003 (1974).
54. NATIONAL AcADEmY OF SCIENCES, GENETIC ScREENiNG: PROCEDURAL GUMANcE
& REcOMMENDATIONS, 1 (1975).
55. Id., at 2-4.
56. Kardon, et al., Pitfalls inPrenatalDiagnosisResultingfrom ChromosomalMosaicism.
80 J. OF PEDIATRICS 297 (1972).
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laboratory, cell contaminations, and human error could all produce
inaccurate test results.
5 7
An example illustrates the possibilities. Assume that the genetic
defect under study appears in one of every 50 subjects, and the test
being used has been developed to a point where it has a sensitivity
of 99 percent (i.e., it correctly classifies 99 percent of all true
positives), and a specificity of 99 percent (i. e., it correctly classifies
99 percent of all true negatives). If this test were used prenatally,
and a decision to abort or not to abort were made on the basis of the






true positive false negative
abort (99) don't abort (1) 100
negative false postive true negative
abort (50) don't abort (4850) 4900
149 4851 5000
Such a test would have a predictive value for a true positive of
about 66 percent and a predictive value for a true negative of about
99.9 percent. The low incidence (1:50) of the genetic defect in this
hypothetical situation means that the number of false negatives will
be low, but at the expense of aborting a relatively large number of
false positives, i.e., while few defective babies will be born after
testing, many healthy babies will be aborted. If the defect occurred
in only one of every 100 subjects, and all other facts remained the
same, such a test would yield as many false positives as true
positives: for every defective fetus aborted, a healthy fetus
would also be aborted. Such a test might nevertheless find
acceptance in the medical profession for two reasons. One, there
has been a traditional concern with letting false negatives "get
57. Friedman, Legal Implications of Amniocentesis, 123 U. PA. L. REv. 92, 103-104
(1974).
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away" (e.g., in cases of communicable diseases) and thus
(especially if the treatment is not dangerous or expensive) one
would rather have more false positives than false negatives. Two, as
abortion "on demand" becomes more acceptable and common-
place to society, a false positive that is aborted may not seem as
tragic to the medical profession.
Presently only about 60 of the more than 1600 known genetic
defects can be prenatally diagnosed by amniocentesis. Since each of
these requires its own "test" or interpretation of chromosome
patterns, the fourfold table analysis can be applied to each of them
separately. The following discussion of remedies presumes
negligence in performance of some aspect of the test, although an
action might lie for breach of contract if the physician guaranteed
the accuracy of amniocentesis.
Remedies for Birth of a Defective Infant
Following Amniocentesis
The threshold question is whether a court should permit any suit
founded, as this one would be, on the concept of "wrongful life."
The argument courts have favored to date is that no such action
should be permitted since, in the words of an early leading
commentator, "whether it would have been preferable for a child
not to be born [is] a problem which admits of no solution," 8 Like
most "unanswerable" questions, however, it simply begs the
relevant one: "Should courts permit compensation for injury
suffered to an individual by the negligence of another, even though
had there been no such negligent act the individual would not have
been born?" So far the arguments against permitting recovery have
not been persuasive.
In the leading case, for example, the New Jersey Supreme Court
denied both the infant and his parents recovery when the child was
born deaf and blind as a result of the rubella his mother suffered
during her pregnancy. The court arrived at this conclusion even
though her physician apparently knew of the possibility of this
injury (estimating its chances at 1:4) and intentionally withheld this
information from the mother. Its stated reason for denying the
child's claim was that it was impossible to make the plaintiff child
58. Tedeschi, On Tort Liability for "Wrongful Life", 1 ISRAEL L. REv. 513, 538 (1966).
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"whole" again, since no one could measure the value of an
impaired life versus no life at all.59 The parents' claim was denied
because they would have chosen abortion, a procedure the court
found would violate "the preciousness of human life." 60 The former
argument is not persuasive, since courts make similar determina-
tions every day in cases involving personal injuries, wrongful death,
and lately in analogous cases concerning negligent failures of
sterilization procedures.6 ' The policy against abortion is also
undermined by the recent Supreme Court decisions stating that
abortion can be a constitutionally protected right.
62
What was probably really at stake (although the court seems
to deny it) is a belief that life itself is always and under all
circumstances a blessing.63 It is, however, precisely because this
premise is not accepted that a couple seeks amniocentesis in the first
place, i.e., their desire is to give birth only to a genetically normal
child. If amniocentesis followed by abortion of affected fetuses is
accepted as an appropriate decision, compensation for birth of an
affected fetus due to medical negligence should also be accepted.
Nothing in any of the other so-called "wrongful life" cases argues
against this conclusion.
64
A recent Texas case with circumstances similar to those in New
Jersey came to a more reasonable conclusion. The Texas court said
59. Gleitman v. Cosgrove, 49 N.J. 22, 227 A.2d 689 (1967).
60. Id.
61. E.g., Custodio v. Bauer, 59 Cal Rptr. 463 (1967); and see generally Annot., Medical
Malpractice, and Measure andElement ofDamages, in Connection with Sterilization or Birth
Control Procedures, 27 A.L.R. 3d 906.
62. Roe v. Wade, 93 S. Ct. 705 (1973), Doe v. Bolton, 93 S. Ct. 739 (1973).
63.See Capron, Informed Decisionmaking in Genetic Counseling: A Dissent to the
"Wrongful Life" Debate, 1971 INDIANA L. J. 581, 595-602.
64. Steward v. Long Island College Hospital, 58 Misc. 2d 432, 296 N.Y.S.2d 41 (Sup. Ct.
1968), modified, 35 App. Div. 2d 531, 313 N.Y.S.2d 502 (1970), affd, 30 N.Y.2d 695, 283
N.E.2d 616,332 N.Y.S.2d 640 (1972) (German measles case in which hospital committee had
refused to permit abortion; court follows Gleitman saying recognition of right to recover must
come from legislature); Zepeda v. Zepeda, 41111. App. 2d 240, 190 N.E.2d 849 (1963), cert.
denied, 379 U.S. 945 (1965) (illegitimate child's action against his father for illegitimacy
dismissed because of the court's belief that granting relief would create too sweeping a prece-
dent and therefore the decision was more properly one for the legislature); Williams v. State,
18 N.Y.2d 481, 223 N.E.2d 343, 276 N.Y.S.2d 885 (1956) (child born as a result of a sexual
assault on a woman confined as a patient in a state mental institution; suit brought against the
state dismissed because of difficulty in measuring damages for illegitimacy, and the potential
far-reaching effects of granting relief); Pinkney v. Pinkney, 198 So. 2d (Fla. Dist. Ct. App.
1967) (an action by a daughter against her father for having caused her birth out of wedlock
and for having shot her mother; action dismissed citing Zepeda as precedent). And see
generally. Waltz & Thigpen, Genetic Screening and Counseling: The Legal and Ethical
Issues, 68 NOnWEST. U. L. REv. 696, 750-67 (1973), and Capron, supra note 63.
478 Family Law Quarterly
it was not necessary to determine the value of life with a defective
body as opposed to no life at all. Instead, one could sue the
negligent physician not for the amount of money it takes to raise a
child, but for the amount of additional money the parents must
spend solely because of the physical defects of the child. The
decision to permit the parents to sue was based on the physician's
failure to inform the mother of the potential risk to her fetus. In the
words of the court:
It is impossible for us to justify a policy which at once deprives the parents of
information by which they could elect to terminate the pregnancy likely to
produce a child with a defective body, a policy which in effect requires that the
deficient embryo be carried to full gestation until the deficient child is born,
and which policy then denies recovery from the tortfeasor of costs of treating
and caring for the defects of the child."
Any woman who employs a physician for prenatal care should
have a right to have the physician fully inform her of any reason he
has to believe that the fetus might be defective, and to further
inform her of the existence of diagnostic tests that might identify
precise genetic defects.66 The physician incurs the duty of
disclosure because it is precisely this kind of information that the
woman employed the physician to learn in the first place, i e., to
learn all she could to help her have a healthy child. If the physician
fails to disclose this information he may be treating the patient
under false pretenses, and accordingly her consent to that
treatment may be invalid. The physician does not guarantee a
healthy child, but the reasonable expectation of the patient is that
she will be apprised of any information the physician has that the
child might be defective and of the alternative ways to proceed, so
that the patient can determine what action to take.
Remedies for the Abortion of a Healthy Fetus
Following Amniocentesis
At least one physician has suggested to his colleagues in writing
that an attempt to sidestep this issue is acceptable practice. In the
words of Dr. Fritz Fuchs: "If [following abortion] the diagnosis
cannot be upheld, and the patient demands to know, the
obstetrician or whoever acts as the genetic counselor is in a delicate
65. Jacobs v. Theimer, 519 S.W.2d 846, 849 (Tex. 1975). Contra Smith v. U.S., 392 F.
Supp. 654 (D.C. Ohio 1975).
66.Cf. Friedman, supra note a7, at t4b-48.
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situation, unless he has made reservations for such a possibility in
advance. He can tell the patient to attempt another pregnancy and,
in my experience, most patients will follow this advice."
'6 7
Another pregnancy may well be advisable, but if negligence was
involved in the faulty diagnosis so is malpractice. In such a suit
assessing damages should present the court with little difficulty,
since the case should be considered one for wrongful death for
damages purposes. Many jurisdictions, for example, have recog-
nized the rights of prospective parents to bring actions for fetal
death negligently caused. 68 While recovery has been limited to
viable fetuses, the main reason for this limitation appears to be the
court's inability otherwise to determine the existence of proximate
cause between the defendant's action and the death of the fetus. 69
With amniocentesis followed by abortion, of course, proving
causation should not present a problem.
Failure to Perforn Amniocentesis as Negligence
Under what circumstances does a physician have a legal duty to
refer his patient to a specialist for the performance of amniocente-
sis? The general rule is that referral to a specialist is required when
the physician knew or should have known that this particular
pregnancy was beyond his own competence. 70 When the plaintiff is
able to establish that her age or medical history indicated that
amniocentesis should at least have been considered, the physician
may be held liable for the birth of a defective fetus if it can be
shown that amniocentesis would have detected the defect and led to
an abortion. 71 The physician should not be permitted to argue that
67. Fuchs, Amniocentesis and Abortion: Methods and Risks, 7 BIRTH DEFECTS 19 (April,
1971).
68. E.g., Hale v. Manion, 189 Kan. 143, 368 P.2d 1 (1962); and cases collected in Annot.,
15 A.L.R. 3d 992 (1967).
69. PROSSER, HANDBOOK OF THE LAW OF TORTS § 55 at 337-8 (4th ed., 1971); and see Mace
v. Jung, 210 F. Supp. 706 (D. Alas. 1962).
70. G.J. ANNAS, RIGHTS OF HOSPITAL PATIENTS, ch. VIII (Consultation, Referral and
Abandonment) (1975).
71. Waltz & Thigpen, supra note 64, at 757. Such cases have actually arisen involving both
Down's syndrome and Tay Sachs. In the only jury case that the writers are aware of a verdict
was returned in favor of the defendant physician who failed to advise a 42-year-old woman in
1971 of the existence of amniocentesis. At the time of trial the plaintiffs Down syndrome
child was 3 /2 years old. Park v. Nissen, Cal. Super. Ct., Orange Co., Docket No. 190033 (Dec.
13, 1974). Facts summarized in 31 TRE CITATION 38 (June 1, 1975). The Tay-Sachs case is
apparently still in the courts. Schneck et al., letter to the editor, 292 NEW ENG. I. MED. 758
(1975).
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he or she made an independent judgment that amniocentesis was
not appropriate and therefore did not discuss it with the
patient-the decision must be the patient's, not the doctor's.
Further, no therapeutic privilege should protect the physician from
nondisclosure in these circumstances since he is not treating the
condition, but actually preventing the mother from making an
informed decision concerning abortion, currently the only available
"treatment" to prevent most genetic diseases.
A more novel, but not inconceivable, approach would hold the
physician negligent for failing to routinely perform amniocente-
sis on all pregnant women with potentially affected fetuses, or for
failing to refer these patients for such testing, even if such routine
testing is not the standard of practice. The rationale would follow
that enunciated in the recent case of Helling v. Carey. 11 There the
supreme court of the state of Washington held that an
ophthalmologist was negligent because he did not routinely
perform a pressure test designed to detect glaucoma, even though
the use of such a test was not standard medical practice among
specialists and the incidence of glaucoma in patients the age of the
plaintiff was approximately one in 25,000. The major rationale the
court used was that the diagnostic test was safe, inexpensive,
simple, and accurate, and could prevent or at least arrest blindness
if routinely performed.73 Therefore, the court reasoned that the
public was entitled to the benefit of the test, and its non-use was
itself evidence of negligence. A minority of the court would have
found against the physicians on the basis of strict liability, on the
theory that while they may not have been personally culpable they
were in the best financial position to bear the loss and obtain
insurance for such statistically predictable missed diagnoses.74
Since amniocentesis presently is relatively expensive, not easy,
not 100 percent accurate, and carries significant risks to both the
mother and fetus, the analogy is not presently persuasive.
Nevertheless, as techniques improve in terms of accuracy and
safety, one can envision application of this analogy to permit
recovery for the birth of a defective child. A court would not have to
72. 83 Wash. 2d 514, 519 P.2d 981 (1974).
73. See Annas, The Case ofthe Simple, Harmless, Inexpensive, Conclusive Diagnotic Test,
4 ORTHOPAEDIC Rav. 67 (Feb. 1975).
74. Id.
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go this far, however, to find a physician liable for not disclosing to
an at-risk patient the existence of this diagnostic test. One possible
rationale could be to find that the physician was treating the patient
throughout the pregnancy and birth without her informed consent
because he had withheld from her a vital piece of material
information-the existence of a test to determine whether or not
her fetus was affected by some specific defect.7 s
Neonatal Screening
As with amniocentesis, screening errors can also be made at birth.
However, the consequences for the newborn are generally not
death, but more likely improper or no treatment, with or without
stigmatization. Two examples illustrate these problems.
In the initial enthusiasm that was created when a screening test
for phenylketonuria (PKU) was developed, 41 states passed laws
from 1963 to 1967 regarding such testing of newborns. 7 6 Most made
testing mandatory for all newborns. 77 PKU is caused by an enzyme
defect that allows phenylalanine to accumulate in the blood, which
leads to irreversible mental retardation. It is thought by most that if
children with an elevated blood level of phenylalanine are detected
early enough and placed on a diet containing no phenylalanine, the
effects of this disorder can be avoided. 78 Unfortunately, experience
has demonstrated that the diet itself "is not without danger," and
phenylalanine deficiency syndrome may cause listlessness, rash,
bone changes, hypoglycemia, anemia, susceptibility to infection
and death. 79 Many infants may have been subjected to the risks
involved in this treatment unnecessarily because of the imprecision
of the tests used to diagnose the disorder.8
In view of the facts that PKU accounts for fewer than one percent
of the institutionalized retarded, is a relatively rare disorder, and
has a controversial treatment of unknown success, it is not un-
75. Cf Milunsky & Reilly, The "New" Genetics: Emerging Medicolegal Issues in the
Prenatal Diagnosis of Hereditary Disorders, 1 AM. J. LAw & MED. 71, 75-76 (1975).
76. Swazey, Phenylketonuria:A Case Study in BiomedicalLegislation, 48 J. URBAN L. 883,
908-09 (1971).
77. Id. and see Screening for Phenylketonuria in NATIONAL ACADiMY OF SCIENCE,
GENETIC SCREENING: PRoGRAMS, PRiNCrPLES & RESEARCH 19-93 (1975).
78. Swazey, supra note 76, at 899-900.
79. Id. at 900-901.
80. Parker, Some LegalAspects of Genetic Counseling, 7 PROGRESS IN MED. GENETICS
217, 220 (1970).
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reasonable to conclude that PKU screening laws must be consid-
ered "premature biomedical legislation."'81 This experience should
teach that voluntary programs should be used as long as feasi-
ble to gain sufficient information about the efficacy of both the
screening test and the intervention planned, and that mandatory
statutes should not be enacted before there is at least a reasonable
medical certainty that the measures they prescribe are both
necessary for the public health and capable of achieving this
legislative purpose. Knee-jerk reaction based on a laudable desire
to help prevent mental retardation may create more problems than
it solves, both by raising unreasonable expectations on the part of
the public and by subjecting certain classes of persons to unproven
testing and treatment.
Another problem, that of potential stigmatization, can be
illustrated by screening the newborn for XYY. In 1962 it was
suggested that this sex chromosome abnormality was associated
with a predisposition to antisocial or criminal behavior. 82 Since
then this theory has been widely debated and generally discredited,
although no prospective study of the problem has yet been made. 3
In an attempt to do such a study, Dr. Stanley Walzer of Boston's
Children's Hospital began in 1968 to screen all newborn males at
the Boston Hospital for Women for XYY and to follow up those
with this chromosome configuration, matching them with another
male child with a normal XY sex pair.84 Putting aside the
controversy that later arose over the type of informed consent
necessary from the mother both for the initial screening and the
81. Swazey, supra note 76, at 927. At least two physicians have, however, been found
negligent for failing to timely diagnose PKU. Naccarato v. Grob, 180 N.W.2d 788 (Mich.
1970), and current medical literature seems to support the treatment's efficacy. See, e.g.,
Smith & Wolff, Natural History of Phenylketonuria and Influence of Eary Treatment,
LANcET 540 (Sept. 1974). Starfield & Holtzman, A Comparison of Effectiveness of Screening
for Phenylketonuria in the United States, United Kingdom and Ireland, 293 N. ENG. J. MED.
118 (1975).
82. Court-Brown, 1962 LANCETf508; and see Jacobs, et al., Aggressive Behavior in Mental
Subnormality and theXYYMale, 208 NATURE 1351 (1967), and Price & Whatmore, Behavior
Disorders and Pattern of Crime among XYY Males Identified at a Maximum Security
Hospital, 1967 BRIT. MED. J. 513.
83. See e.g., SHAH, REPORT ON THE XYY CHRomosomSAL ABNORMALITY, (U.S. Gov.
Print. Office, 1970); Note, XYY Syndrome and the Judicial System, 6 N.C. CENT. L. J. 66
(1974).
84. See discussion in GENETICS AND THE LAw (Milunsky & Annas eds., in press). In June,
1975 Dr. Walzer decided to discontinue his research because "he had become worn down by
harassment, unrelenting controversy and the threat of further opposition to his work by groups
supporting children's rights." N.Y. Times, June 20, 1975 at 30, col. I.
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follow-up studies, a serious question of stigma can be raised.
With XYY thought by most of the scientific community to be no
more disposed to violence or antisocial behavior than its "normal"
counterpart, XY, why should parents have it suggested to them that
their child is "abnormal" in this regard? Furthermore, what
protections must be taken to insure that this information is not
transmitted to the police or school authorities, who may pay more
attention to this individual because of his chromosome makeup?
Because of society's profound interest in and fascination with
genetics and eliminating "defectives" or deviance, one must be
extremely careful in classifying a certain genetic trait as potentially
harmful to society, because the pressures to eliminate it (or its
carriers) will be intense whether the thesis is correct or not. No
matter what the literature, for example, XYY may be considered a
''serious" enough "abnormality" to lead most couples who have
undergone amniocentesis for another reason to choose an abortion
for this reason alone even if the child would probably otherwise be
normal. Premature publicity may make a reasoned discussion of
the current state of knowledge concerning XYY extremely difficult.
As will be discussed in the next section, the trend toward more
genetic screening will lead to increased pressures for central
registries and wider application of the information obtained. As
genetic information is used for more and more purposes (and the
probability of stigmatization based both on medical fact and
popular beliefs increases), measures to insure both its accuracy and
confidentiality become increasingly important.
Screening of Children and Adults
Screening in this group is almost always done as a prelude to
genetic counseling concerning marriage or reproduction, although
there have been examples of attempts to screen as a prerequisite for
entry into grade school. Unlike newborn screening, these tests have
almost always been voluntary. The major programs thus far have
involved hereditary diseases concentrated in specific racial groups,
Tay-Sachs in Ashkenazic (Eastern European origin) Jews and sickle
cell disease in Blacks.
Tay-Sachs is a severe autosomal recessive condition character-
ized by blindness, severe mental retardation, and early death,
usually before three years of age. Its incidence in Ashkenazic Jews
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is about one in every 3,600 births. A number of large voluntary
screening programs to identify carriers have been undertaken in
the U.S. Since the disease has such horrible consequences to the
child, and since it can be tested in utero, couples who are both
carriers can still be assured of having healthy children provided the
woman undergoes amniocentesis during pregnancy. Because of the
high motivation not to have such a child, and the ability both to
relieve anxiety in non-carriers and to provide an alternative for
carriers, this type of screening has been generally well-accepted."'
Tay-Sachs is to be contrasted to sickle cell disease, a disorder of
the blood in which the red cells assume a sickle or hollyleaf shape.
Associated with the disease are hemolysis (breakdown of red cells)
with resulting anemia, or occlusion of blood vessels which can lead
to painful cycle cell crises. The disease may manifest itself in
infancy or as late as the second year of life, and continues
throughout one's life. Persons with sickle cell trait, however, rarely
show any clinical symptoms.
About 7-9 percent of the U.S. Black population carry the trait,
and about 0.3 percent suffer from the disease.6 6 In 1970 a simple,
inexpensive and relatively reliable test for sickle cell hemoglobin
was made available.8 7 Shortly thereafter, influenced by strong
lobbying led by the Cynthia Foundation, a number of states,
beginning with Massachusetts, passed laws mandating sickle cell
screening at various times.68 What followed was a reaction by the
Black community on two fronts: the first pushing for more medical
research into the problem; the second calling for screening on a
purely voluntary basis.
85. E.g., Kaback, Zeiger & Reynolds, Tay-Sachs Disease: A Model for the Control of
Recessive Genetic Diso'ders, PROCEEDINGS OF THE FouRTH INTERNATIONAL CONFERENCE,
VIENNA, AUSTRIA, SEPT. 2-8, 1973, EXCERPTA MEDICA 248-262 (1974). An advisory commit-
tee of physicians in the city of Dayton, Ohio did, however decide to oppose a mass screening
program for Tay-Sachs on concluding that screening the 1800 Ashkenazic Jews between the
ages 16 and 45 to prevent the predicted birth of one child with the disease would not be worth
the price in terms of increased anxiety in the 72 heterozygous carriers that would be identified
in the screening program. Kuhr, Letter to the Editor: Doubtful Benefits of Tay-Sachs
Screening, 292 NEwENG. J. MED. 371 (1975). This decision has been subjected to criticism as
an example of a "paternalistic attitude that new genetic knowledge imparted to the public may
be more harmful than useful," and as "a disservice to the Ashkenazic Jewish community of
Dayton." Schneck, Saifer &Volk, Letter to the Editor: Benefits of Tay-Sachs Screening, 292
NEW ENG. J. MED. 758 (1975).
86. Binder & Jones, Prevalence and Awareness of Sickle Cell Hemoglobin in a Military
Population, 214 J.A.M.A. 909 (1970).
87. Loh, A New Solubility TestforRapidDetection ofHemoglobin S., 61 K INDIANA STATE
MED. Assoc. 1651 (1q68).
88. Se-e generally, Reilly, Sickle Cell Anemia, J. LEGAL MED. 39 (Sept. -1973).
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In 1972 the U.S. Congress, in response to a major address by
former President Nixon, passed the National Sickle Cell Anemia
Control Act. While $115 million was authorized under this act, no
monies were actually appropriated, and what funding did occur
came from other HEW sources. The act's express limitation on
federal funding to voluntary programs, however, appears to have
had an impact. Since that time more than half of the states with
mandatory laws have replaced them with voluntary ones and made
provisions for safeguarding confidentiality. 89 Such safeguards were
deemed essential since this genetic information was sometimes used
to deny employment and insurance. Moreover, the wisdom of these
laws began to be questionable, since there was no method to detect
sickle cell disease in utero through amniocentesis, and their only
purpose seemed to be to warn couples who both had the trait not to
have children (one in four of whom would have the disease), and to
warn unmarried carriers not to marry carriers. Because this disease
is concentrated in the Black population, the charge by that group
that what was involved was an attempt to reduce Black re-
production cannot be easily dismissed. With this type of racial
concentration, voluntariness in the program is especially impor-
tant. 90 While none of these laws have been challenged as to their
constitutionality, serious doubts could certainly be raised. The
Kentucky law, for example, specifically applied only to those "of
the Negro race. '"91
89. Curran, supra note 53.
90. See, e.g., Fort, et al., Counseling the Patient with Sickle Cell Disease about Reproduc-
tion: Pregnancy Outcome Does Not Justify the Maternal Risk, 111 AM. J. OBSTET.
GYNECOL. 324-27 (1971). Based on a six percent maternal mortality rate and a 20 percent
infant mortality rate among mothers with sickle cell disease these authors state: "We advocate
primary sterilization, abortion if conception occurs, and sterilization for those that have com-
pleted pregnancies. Patients with sickle cell disease should be unhesitatingly thus counseled."
While the authors might argue that such "counseling" is for the patient's own good, what is
really at stake is an attempt by a group of physicians with specific beliefs, which could be
viewed as racist or even genocidal, to impose those beliefs on a defined population of
patients-regardless of the patient's own opinion concerning the appropriateness of taking
such risks.
91. KENT. REV. STAT. § 402.310.
Sickle cell anemia is of relatively frequent occurence not only in Blacks but also in
Meditteranean peoples and, generally, wherever falciparum malaria has been a problem.
Motulsky, A. G., Current Concepts on the Genetics of the Thalassemias, 29 COLD SPRING
HARBOR SYMP. QUANT. BIOL. 399 (1964).
The Thalassemias are a group of inherited disorders in which the synthesis of one or more of
the polypeptide chains of hemoglobin is suppressed, either partially or totally. The clinical
picture varies with the particular genetic defect from barely detectable to severely anemic. The
most common form of Thalassemia is Cooley's anemia, also referred to as Mediterranean
anemia of Thalassemia because of the high frequency in persons of Mediterranean
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Confidentiality in Genetic Screening
No one should be screened without his or her prior, fully informed,
consent. Since the genetic basis of disease is not well understood by
the general population, special efforts are necessary to make the
implications of a positive finding known to the individual prior to
screening. The potential hazards of stigmatization, loss of
employment or insurance, and family discord should all be openly
emphasized, as well as the possibilities of a false-positive or
false-negative finding. The procedure should be fully explained to
the individual, and the individual should be granted complete
access to all his or her medical records regarding the test and its
interpretation. The individual should also have the right to refuse
to permit any person other th1an his or her physician or the person
in charge of the screening program to see or copy these records
without his or her prior written permission, unless a third party
with a legitimate interest in the data could in no way identify the
patient from the record. As in amniocentesis, it seems apparent
that the subject of the screening process has the right to all
information obtained, except where he or she has made a voluntary
and informed prior agreement restricting access to the findings.92
The much more difficult question that arises in this context is the
right or duty of the physician-counselor to inform potentially
affected relatives of the findings. If one of the parents is found to be
a carrier of a serious genetic disease, can the physician inform
potentially affected relatives? For example, if the mother is found
to be a carrier of the Lesch-Nyhan syndrome through an affected
son, can the physician inform the mother's sisters?93 Assuming that
the affected parents refuse to give the physician permission to notify
their relatives who might also be affected, what should the
physician do? The remedy of a suit for breach of confidence is
inadequate protection for the patient, as it necessarily involves
background. Cooley's anemia manifests itself as a severe anemia characterized by
enlargement of liver and spleen, high white blood cell count, thickening of the diploe and long
bones, and early mortality. For details, see GOODMAN, R. M., GENETIC DISORDERS OF MAN
(1970) at 176. Demands for Thalassemia screening have been expressed in the United States by
people of Mediterranean background. See Peason, H A., et al., Screening for Thalassemia
Trait by Electronic Measurement of Mean Corpuscular Volume, 288 N. ENG. J. MED. 351
(1973).
92. See generally NATIONAL SCIENCE FOUNDATION, GENETIC SCREENING, supra note 77,
at 251-64.
93. MILUNSKY, THE PRENATAL DIAGNOSIS OF HEREDITARY DISORDERS (1973) at 159.
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public disclosure of the information the patient desires to be kept
secret. Therefore the doctrine of informed consent prior to
counseling (and screening), and again prior to disclosure to third
parties, may help create an atmosphere that encourages strict
observance of confidentiality, because the informed patient will
probably not consent to screening and counseling in the first place
if provisions for data confidentiality are known and perceived as
being inadequate.
There is a long line of cases that permits a physician to disclose
the diagnosis of a contagious disease to all who need this
information in order to protect themselves from contracting the
disease. 94 Statutes have also been enacted that require physicians to
disclose confidential medical information to public authorities in
certain circumstances (e.g., some contagious diseases, gunshot
wounds, child abuse, etc.), under the police power of the state to
protect the health and safety of its citizens. 9" In such cases the
physician has an affirmative duty to disclose what would otherwise
be confidential medical information. While none of these seems to
apply directly to the genetic counseling situation, a recent
California case has indicated that the duty of a physician to warn
potentially affected third parties of confidential medical informa-
tion may be very broad indeed.
In enunciating a general rule based on a case in which a
psychologist failed to warn a woman that his patient had threatened
to kill her (the woman was, in fact, murdered by the patient), the
court said: "Where a doctor . . . in the exercise of his professional
skill and knowledge, determines, or should determine, that a
warning is essential to avert danger arising from the medical or
psychological condition of his patient, he incurs a legal obligation
to give that warning. ' ' 96 The basis for this far-reaching and
arguably unprecedented decision was the court's belief that we live
in an "interdependent" and "risk-infested" society, and that
members of such a society cannot tolerate being exposed to
additional risks that physicians could eliminate by a simple act of
communication.
94. Annas, Law & Psychiaty: When Must the Doctor Warn Others of the Potential
Dangerousness of His Patient's Condition? 3 MEDICOLEGAL NEWS 173 (April, 1975).
95. G.J. ANNAS, THE RiGrs op HosPrrAL PATIENTS, ch. XI (Confidentiality and Privacy)
(1975).
96. Tarasoff v. Regents of U. of Cal., 118 Cal. Rptr. 129, 529 F.2d 553 (1974).
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It would be stretching this decision considerably to find a duty on
the part of a genetic counselor to warn other family members that
their offspring might be in danger because of a gene the family
member might be carrying. However, in view of the public policy
enunciated by this and other courts, a strong argument can
certainly be made that such a disclosure would be permissible even
if not required. Given this type of uncertainty in the law, and the
fact that this situation can easily be anticipated as counseling
becomes more widespread, it would seem appropriate that this be
the subject of legislation. The policy of routine disclosure or of
strict nondisclosure would be dictated by the view that the
legislature took of the primary purpose of screening and
counseling-the promotion of individual autonomy in making
procreative decisions, or the minimization of certain genetic defects
in the species. Unless and until such legislation is enacted, it is
extremely important that the genetic counselor make clear, both
verbally and in writing, the policy that he or she follows so that the
patient can refuse to be screened or counseled if he or she is not in
agreement with the policy. Such a policy is, of course, also
necessary in deciding whether or not to obtain a complete listing of
blood relatives as a routine part of the medical history.
The possibility of a central registry of genetic defects raises
analogous problems of privacy and confidentiality, but with even
more potential for abuse. The issues are similar to those involved in
any centralized system of medical records keeping. First, any such
system should be used to store identifiable patient data only with
the fully informed authorization of the patient. Second, all
information should be available for inspection and correction by
the patient. Third, the information should be stored in such a way
that gross data on incidence and prevalence can be made available
to researchers and policy-makers without identifying any individual
patient. Finally, access to the information by unauthorized third
parties (i. e., parties not authorized by the patient) should be strictly
guarded against, with the central registry liable in tort for the
foreseeable consequences of giving out information without
authorization. 97
97. ANNAS, supra note 95.
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Conclusion
It is a cliche to say that we stand on the frontier of the genetic era.
Most of the techniques discussed in this article are products of the
past decade. That any laws have been passed dealing with them is
somewhat of a marvel. That almost no cases have come before the
courts specifically on point should not be surprising. Nevertheless,
the legal issues raised by genetic screening are not unique, and are
susceptible to legal analysis by analogy to many of the more
familiar problems in traditional medical decision-making. The
challenge for the courts is to view genetic advances as steps in a
continuum to enhance man's ability to control his life and that of
his offspring. The challenge for state and federal legislatures is
to carefully examine genetic advances and determine the ap-
propriate governmental role in regulating and fostering their
development in a manner which will enhance human rights. The
challenge for the attorney counseling individual clients on these
matters is to be knowledgeable enough to be able to recommend
appropriate courses of action and appropriate experts to consult.
While genetic screening raises important racial, informational,
scientific and constitutional problems in a novel context, the law
can be an able guide to reasonable solutions.

